Correction: Camptothecin-based prodrug nanomedicines for cancer therapy
Source abstract
Abstract
Correction for ‘Camptothecin-based prodrug nanomedicines for cancer therapy’ by Renshuai Zhang et al. , Nanoscale , 2023, 15 , 17658–17697, https://doi.org/10.1039/D3NR04147F.
Only a short abstract or summary was supplied by the source.
Source: crossref · Quality: short
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Cancer Institute of The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266061, China
Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital, Qingdao, 266071, China
The Affiliated Hospital of Qingdao University, Qingdao 266061, China
Funding
Natural Science Foundation of Shandong Province · National Natural Science Foundation of China · Shandong Provincial Postdoctoral Science Foundation
References
Reference metadata was not supplied for this record.